en

PRODUCT DETAIL

IRESSA 250 mg filmom obalené tablety

Code 78264
MA number EU/1/09/526/001
Product Form: tbl flm 30(3x10) x 250 mg (blis.PVC/Al perfor.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XE Protein kinase inhibitors
L01XE02 Gefitinib
Shelf life: 48
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 24.06.2009
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.04.2019
eu-flag.png sk-flag.png